Cystic Fibrosis, CFTR, and Colorectal Cancer
Cystic fibrosis (CF), caused by biallelic inactivating mutations in the <i>cystic fibrosis transmembrane conductance regulator</i> (<i>CFTR</i>) gene, has recently been categorized as a familial colorectal cancer (CRC) syndrome. CF patients are highly susceptible to early, ag...
Main Authors: | Patricia Scott, Kyle Anderson, Mekhla Singhania, Robert Cormier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/8/2891 |
Similar Items
-
CFTR and Gastrointestinal Cancers: An Update
by: Rahul Bhattacharya, et al.
Published: (2022-05-01) -
Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01) -
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility
by: Giuseppe Fabio Parisi, et al.
Published: (2023-08-01) -
Cross‐talk between CFTR and sphingolipids in cystic fibrosis
by: Dorina Dobi, et al.
Published: (2023-09-01)